Dementia news from FiercePharma
News
Study: Antipsychotics hike stroke risk for all
The risk of stroke among patients taking antipsychotics may be more widespread than we thought. British researchers are saying that the risk accompanies all antipsychotics--not just the newer Read more...
Wrong drugs used in dementia, experts say
The debate over drug use in dementia patients continues apace. A New York Times article today trots out the stats -- about one-third of nursing home patients have been prescribed antipsychotics, for Read more...
Enbrel, antipsychotics draw warning fire
Warning, warning. Two new safety stories from the FDA hit the press yesterday: One on Amgen's rheumatoid arthritis and psoriasis drug Enbrel and one on older antipsychotic meds such as haldol and Read more...
Get more Dementia coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets